Autologous conditioned serum in the treatment of neck pain

Comparison of the analgesic non-inferiority of ultrasound-guided injections of ACS (Orthokine) into the cervical fascial planes versus application along the cervical facet joints in patients with neck pain: A randomized, open-label, controlled clinical trial. (Protocol).

Registry ID
ISRCTN38950110
Source registry
ISRCTN
Status
No longer recruiting
Study type
INTERVENTIONAL
Sponsor
Sutherland Medical Center
Enrollment
100
Start date
2023-04-01
Completion date
2023-12-31
Last update
2026-08-17

Conditions

Summary

Cervical pain of degenerative, overload, and post-traumatic origin

Detailed description

Randomization is carried out using computer-generated random numbers (simple randomization). The participants are randomly assigned to groups in a 1:1 ratio: Group A: injections into the fascial planes of the cervical section at palpation points under ultrasound guidance, four Autologous Conditioned Serum (ACS) injections every 3 days Group B: injections into the joint column of the cervical section under ultrasound guidance, four Autologous Conditioned Serum (ACS) injections every 3 days The total duration of treatment is 10 days.

Interventions

Inclusion criteria

1. Adults (aged 18 years and over) 2. Pain in the cervical section of degenerative, overload, post-traumatic origin 3. Consenting to the injection

Exclusion criteria

1. Pregnant women 2. People with cancer 3. Presence of systemic inflammatory diseases 4. Injuries requiring surgical treatment 5. Anticoagulants that cannot be withdrawn 6. No consent to injection 7. No doctor approval

Locations

Related clinical trials

View on source registry